Literature DB >> 21766437

Teratogenic exposures.

Sarah Običan1, Anthony R Scialli.   

Abstract

A consideration of teratogenic exposures includes not only an agent (chemical, radiation, biologic) but an exposure level and timing of exposure. There are criteria by which exposures are evaluated for a causal connection with an abnormal outcome. We here review some teratogenic exposures and discuss how they were initially described and confirmed. We have limited our discussion to some of the exposures for which a connection to structural malformations has been accepted in some quarters, and we indicate some exposures for which a causal association awaits confirmation. We recommend that counselors find a reliable and updatable source of information on exposures during pregnancy.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21766437     DOI: 10.1002/ajmg.c.30310

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  15 in total

1.  Most Frequently Reported Prescription Medications and Supplements in Couples Planning Pregnancy: The LIFE Study.

Authors:  Kristin Palmsten; Katrina F Flores; Christina D Chambers; Lauren A Weiss; Rajeshwari Sundaram; Germaine M Buck Louis
Journal:  Reprod Sci       Date:  2017-04-12       Impact factor: 3.060

Review 2.  Genetic basis of congenital cardiovascular malformations.

Authors:  Seema R Lalani; John W Belmont
Journal:  Eur J Med Genet       Date:  2014-04-30       Impact factor: 2.708

3.  Congenital Malformations and Consequential Epidemiology.

Authors:  Martha M Werler
Journal:  Curr Epidemiol Rep       Date:  2015-03

4.  Medication use among pregnant women with systemic lupus erythematosus and general population comparators.

Authors:  Kristin Palmsten; Julia F Simard; Christina D Chambers; Elizabeth V Arkema
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

Review 5.  Human teratogens update 2011: can we ensure safety during pregnancy?

Authors:  Sonja A Rasmussen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-02-13

6.  Discussing Appropriate Medication Use and Multivitamin Intake with a Healthcare Provider: An Examination of Two Elements of Preconception Care Among Latinas.

Authors:  Julia D Interrante; Alina L Flores
Journal:  J Womens Health (Larchmt)       Date:  2017-10-27       Impact factor: 2.681

7.  Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011.

Authors:  Julia D Interrante; Elizabeth C Ailes; Jennifer N Lind; Marlene Anderka; Marcia L Feldkamp; Martha M Werler; Lockwood G Taylor; James Trinidad; Suzanne M Gilboa; Cheryl S Broussard
Journal:  Ann Epidemiol       Date:  2017-09-20       Impact factor: 3.797

8.  Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists.

Authors:  Molly M Lynch; Jacqueline B Amoozegar; Emily M McClure; Linda B Squiers; Cheryl S Broussard; Jennifer N Lind; Kara N Polen; Meghan T Frey; Suzanne M Gilboa; Janis Biermann
Journal:  Qual Health Res       Date:  2017-10-03

9.  Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma.

Authors:  Kristin Palmsten; Avanthi Hulugalle; Gretchen Bandoli; Grace M Kuo; Shayda Ansari; Ronghui Xu; Christina D Chambers
Journal:  Paediatr Perinat Epidemiol       Date:  2017-10-03       Impact factor: 3.980

Review 10.  Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.

Authors:  Jennita Reefhuis; Owen Devine; Jan M Friedman; Carol Louik; Margaret A Honein
Journal:  BMJ       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.